Dr. RR Baliga's 'Podkast for the Kurious Doc'

Dr. RR Baliga's 'Podkast for the Kurious Doc'

Left atrial appendage closure—promise meets proof, and proof meets pause.   In The New England Journal of Medicine, two pivotal trials draw a nuanced arc: CHAMPION-AF shows noninferior stroke prevention with less bleeding vs direct oral anticoagulants, while CLOSURE-AF tempers enthusiasm—failing noninferiority in older, high-risk patients with meaningful procedural risk.   The message is elegant and sobering: innovation must bow to evidence, and patient selection remains paramount.   In atrial fibrillation, the art lies not in closing the appendage—but in opening judgment....

Dr. RR Baliga's 'Podkast for the Kurious Doc'

Evolocumab steps into primary prevention—quietly, convincingly. In JAMA, the VESALIUS-CV analysis shows that high-risk patients with diabetes without known atherosclerosis experienced a 31% relative reduction in first MACE (HR 0.69), with LDL-C lowered to ~52 mg/dL. The signal is clear: earlier, deeper lipid lowering matters. Yet questions remain—cost, long-term safety, and who benefits most. Are we ready to treat risk before disease declares itself? 🧠💉📉 #JAMA #Cardiology #Prevention

Dr. RR Baliga's 'Podkast for the Kurious Doc'

A quiet valve, a loud message. 🫀 The 10-year follow-up of the RECOVERY trial in The New England Journal of Medicine shows that early surgery in asymptomatic very severe aortic stenosis is not premature—it is protective. A striking reduction in cardiovascular mortality (HR 0.10, P=0.002) and sustained divergence of Kaplan–Meier curves challenge the long-held “watchful waiting” paradigm. Perhaps we are not treating symptoms—but preventing myocardial destiny. #Cardiology #AorticStenosis #NEJM #PrecisionMedicine

Dr. RR Baliga's 'Podkast for the Kurious Doc'

Cardiology stands at a quiet inflection point. We have spent decades treating plaque—yet the real opportunity lies upstream: preventing atheroma before it begins. Emerging evidence reminds us that cumulative LDL exposure, not just snapshots of risk, shapes lifelong cardiovascular destiny.   A shift is underway: → From 10-year risk to lifetime risk → From reactive care to proactive prevention → From treating disease to preserving vascular resilience Lower LDL earlier. Sustain it longer. That is not just prevention—it is strategy, science, and stewardship. #Cardiology #Prevention...

Dr. RR Baliga's 'Podkast for the Kurious Doc'

Resistant Hypertension remains one of the most under-recognized yet high-risk phenotypes in cardiovascular medicine. Nearly 1 in 5 treated patients meet criteria for apparent resistance—and up to half may reflect nonadherence or white-coat effect.   This concise visual series distills key insights from a recent JAMA review on diagnosis, pathophysiology, and stepwise management—including the pivotal role of spironolactone and emerging therapies like renal denervation.   Precision begins with correct classification. Treatment begins with clarity. 💡   #Hypertension...

Dr. RR Baliga's 'Podkast for the Kurious Doc'

Sound. Mask. Mastery 🎼   A fascinating insight from C. V. Raman reminds us that hearing is not just perception—it is physics in motion. His 1926 Nature note reveals how lower tones quietly veil higher ones, shaping what we think we hear.   In music—and in science—what is hidden often matters most.   #Acoustics #CVRaman #Psychoacoustics #SoundScience #NatureJournal

Dr. RR Baliga's 'Podkast for the Kurious Doc'

Yajnavalkya: Vedic Sage • Radical Thinker • Timeless Voice 🕉️📜✨   What does it mean to know the Self? Long before modern philosophy, Yajnavalkya in the Brihadaranyaka Upanishad asked—and answered—with striking clarity.   “Neti, Neti” (not this, not this) strips illusion, revealing the essence of consciousness—Atman as Brahman.   In dialogues with Maitreyi and Gargi, he models fearless inquiry, intellectual rigor, and spiritual depth.   Ancient, yet urgent. Subtle, yet transformative.   #IndianPhilosophy #Vedanta #Yajnavalkya #Consciousness...

Dr. RR Baliga's 'Podkast for the Kurious Doc'

Emerging insights from Nature Spotlight on Nutrition sharpen a simple truth: what we eat matters—but when and how may matter just as much. Morning coffee aligns with lower cardiovascular mortality, plant-forward diets sculpt a favorable microbiome, early-life sugar exposure imprints lifelong risk, and not all potatoes are equal—fried forms carry harm, not the humble baked.   Nutrition is no longer advice—it is biology, timing, and destiny intertwined.

Dr. RR Baliga's 'Podkast for the Kurious Doc'

Dopamine is not just the “pleasure chemical”—it is the brain’s teaching signal 🧠✨   New insights (from Nature) suggest dopamine shapes how we learn, prioritize, and act—not only through reward, but also via attention, action, and even threat detection 🎯🔁   This evolving paradigm has profound implications for ADHD, addiction, and behavioral medicine 🩺   I’ve summarized the science into a concise slide deck for clinicians and learners.   Curious to hear your thoughts—are we ready to move beyond the reward model? 🚀

Dr. RR Baliga's 'Podkast for the Kurious Doc'

A striking study in Science Translational Medicine reveals that the blood–brain barrier remains disrupted years after retirement in contact-sport athletes. This persistent leakiness is linked to systemic inflammation, complement activation, and measurable cognitive decline.   Notably, imaging of BBB dysfunction outperformed conventional blood biomarkers—offering a potential path toward early detection of CTE risk in living individuals.   The key insight: it’s not single concussions, but the cumulative burden of head trauma that shapes long-term brain health.